Leon Cooperman’s Surgalign Holdings SRGA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-124,999
Closed -$435K – 60
2022
Q3
$435K Hold
124,999
– – 0.03% 45
2022
Q2
$426K Sell
124,999
-1
-0% -$6 0.03% 45
2022
Q1
$1.14M Buy
125,000
+14,133
+13% +$215K 0.06% 44
2021
Q4
$2.38M Buy
110,867
+59,590
+116% +$1.59M 0.12% 44
2021
Q3
$1.68M Buy
51,277
+14,277
+39% +$523K 0.09% 45
2021
Q2
$1.54M Sell
37,000
-1,333
-3% -$68.3K 0.09% 46
2021
Q1
$2.51M Sell
38,333
-25,302
-40% -$1.77M 0.16% 42
2020
Q4
$4.18M Sell
63,635
-2,183
-3% -$142K 0.3% 37
2020
Q3
$3.57M Sell
65,818
-1,200
-2% -$91.8K 0.35% 32
2020
Q2
$6.39M Buy
67,018
+13,955
+26% +$1.04M 0.73% 27
2020
Q1
$2.72M Buy
53,063
+29,158
+122% +$3.05M 0.35% 32
2019
Q4
$1.96M Buy
23,905
+11,472
+92% +$804K 0.1% 50
2019
Q3
$1.06M Buy
12,433
+4,249
+52% +$454K 0.06% 52
2019
Q2
$1.04M Buy
8,184
+1,584
+24% +$228K 0.06% 52
2019
Q1
$1.19M Buy
+6,600
New +$955K 0.07% 47

Other funds holding SRGA

Leon Cooperman's SRGA Position: Q4 2022 in Review

Leon Cooperman sold out of Surgalign Holdings (SRGA) in Q4 2022, closing a stake of 124,999 shares — an estimated $435K sold.

Leon Cooperman first reported a position in SRGA in Q1 2019 and held it in 15 quarters. The position peaked at $6.39M in Q2 2020. 34 funds tracked by Wall St. Rank hold SRGA as of Q4 2022.

  • Leon Cooperman reported no remaining Surgalign Holdings position as of Q4 2022 after selling out during the quarter.
  • Leon Cooperman sold 124,999 Surgalign Holdings shares in Q4 2022, an estimated $435K.
  • Leon Cooperman first reported a position in Surgalign Holdings in Q1 2019 and held it in 15 quarters.
  • Leon Cooperman's Surgalign Holdings position peaked at $6.39M in Q2 2020.
  • 34 funds tracked by Wall St. Rank held Surgalign Holdings as of Q4 2022.

Based on Cooperman Leon G's 13F filing for Q4 2022, filed 30 Aug 2023.